Israele - inglese - Ministry of Health

glaxo smith kline (israel) ltd - betamethasone as valerate - ointment - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - betamethasone valerate is a potent topical corticosteroid indicated for adults, elderly and children over 1 year for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses.these include the following:atopic dermatitis (including infantile atopic dermatitis)nummular dermatitis (discoid eczema)prurigo nodularispsoriasis (excluding widespread plaque psoriasis)lichen simplex chronicus (neurodermatitis) and lichen planusseborrhoeic dermatitisirritant or allergic contact dermatitisdiscoid lupus erythematosusadjunct to systemic steroid therapy in generalised erythroderma

Israele - inglese - Ministry of Health

cts chemical industries ltd, israel - tretinoin - gel - tretinoin 0.05 %w/w - tretinoin - tretinoin - treatment acne vulgaris.

Israele - inglese - Ministry of Health

cts chemical industries ltd, israel - tretinoin - cream - tretinoin 0.05 %w/w - tretinoin - tretinoin - acne vulgaris.

Israele - inglese - Ministry of Health

cts chemical industries ltd, israel - tretinoin - cream - tretinoin 0.025 %w/w - tretinoin - tretinoin - treatment of acne vulgaris.

Israele - inglese - Ministry of Health

cts chemical industries ltd, israel - tretinoin - gel - tretinoin 0.025 %w/w - tretinoin - tretinoin - treatment of acne vulgaris.

Israele - inglese - Ministry of Health

neopharm ltd - erythromycin; tretinoin - solution - erythromycin 4 g / 100 g; tretinoin 0.025 g / 100 g - erythromycin, combinations - erythromycin, combinations - all forms of acne, both non-inflammatory forms with comedones and inflammatory forms with papules and pustules, particularly in the case of fat-rich skin.

Israele - inglese - Ministry of Health

abic marketing ltd, israel - loteprednol etabonate; tobramycin - ophthalmic suspension - tobramycin 3 mg/ml; loteprednol etabonate 5 mg/ml - tobramycin - tobramycin - zylet is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies.the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.the particular anti-infective drug in this product (tobramycin) is active against the following common bacterial eye pathogens:staphylococci, including s. aureus and s. epidermidis (coagulase-positive and coagulase-negative), including penicillin-resistant strains. streptococci, including some of the group a-beta-hemolytic species, some nonhemolytic species, and some streptococcus pneumoniae. pseudomonas aeruginosa, escherichia coli, klebsiella pneumoniae, enterobacter aerogenes, proteus mirabilis, morganella morganii, most proteus vulgaris strains, haemophilus influenzae, and h. aegyptius, moraxella lacunata, acinetobacter calcoaceticus and some neisseria species.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - brimonidine tartrate 5 mg/g equivalent to 3.3mg/g brimonidine;   - topical gel - 3.3 mg/g - active: brimonidine tartrate 5 mg/g equivalent to 3.3mg/g brimonidine   excipient: carbomer 974 glycerol methyl hydroxybenzoate phenoxyethanol propylene glycol sodium hydroxide titanium dioxide - mirvaso is indicated for the treatment of facial erythema of rosacea in adult patients

Australia - inglese - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - ivermectin, quantity: 10 mg/g - cream - excipient ingredients: glycerol; isopropyl palmitate; carbomer copolymer (type b); dimeticone 20; disodium edetate; citric acid monohydrate; cetyl alcohol; stearyl alcohol; ceteareth-20; sorbitan stearate; methyl hydroxybenzoate; propyl hydroxybenzoate; phenoxyethanol; propylene glycol; oleyl alcohol; sodium hydroxide; purified water - vastreka is indicated for the topical treatment of inflammatory lesions of rosacea (papulo-pustular) in adult patients 18 years and over.

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

leo pharma - betamethasone valerate; fusidic acid - cutaneous cream - 1mg/1gram ; 20mg/1gram